Login
Related Links
Phase II
Once the initial safety of the study drug has been confirmed in Phase I trials, Phase II trials are performed on larger groups (20-300) and are designed to assess how well the drug works, as well as to continue Phase I safety assessments in a larger group of volunteers and patients. When the development process for a new drug fails, this usually occurs during Phase II trials when the drug is discovered not to work as planned, or to have toxic effects.
Some Phase II trials are designed as case series, demonstrating a drug's safety and activity in a selected group of patients. Other Phase II trials are designed as randomized clinical trials, where some patients receive the drug/device and others receive placebo/standard treatment. Randomized Phase II trials have far fewer patients than randomized Phase III trials.
Clinical Trial Information
- General Information
- Clinical Trials Design
- Clinical Trial Phases
- Risks and Benefits of Clinical Trials
- Participate in Clinical Trial
- Informed Consent
- Locating Clinical Gene Therapy Trials
- Medical Tourism
- Recently received Clinical Gene Therapy Trials
- Search Clinical Gene Therapy Trials
- Clinical Trials Databases